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A B ST R AC T 
 
 
Pericardial effusion is a common pathology in clinical practice. The etiology 
of pericardial effusion is diverse, from infectious diseases, malignancies, 
autoimmune diseases, chronic renal failure, to drug-related or after an 
invasive cardiac intervention. Clinical presentation of pericardial effusion is 
variable, depending on the volume of the fluid and the rate of accumulation. 
Clinical manifestations are dramatic if the pericardial fluid accumulates 
rapidly. Classical symptoms in pericardial effusion include pleuritic chest 
pain associated with dyspnea. In case of cardiac tamponade, orthopnea, 
jugular venous distension, pulsus paradoxus, hypotension, and shock appear. 
Transthoracic echocardiography is the gold standard investigation for the 
diagnosis of pericardial effusions. The echocardiographic signs of cardiac 
tamponade are represented by the collapse of the right atrium and right 
ventricle, respiratory alteration of mitral and tricuspid flow, and changes of 
the inferior vena cava. Management of pericardial effusion is guided by 
several factors, including hemodynamic impact and etiology. 
Pericardiocentesis guided by echocardiography is a life-saving procedure in 
cases of large pericardial effusions and cardiac tamponade. This is a review 
of the diagnosis and treatment of pericardial effusion.   
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The pericardium is a double-layered membrane that 
covers the heart. It consists of a fibrous and a serous layer 
and encloses the pericardial cavity, which contains, 
physiologically, 15-50 mL of pericardial fluid. The 
pericardium provides mechanical protection of the heart 
and against infections.  
Pericarditis is a common pathology, caused by 
inflammation of the pericardium. Usually, pericarditis is 
associated with pericardial effusion, by accumulation of 
pericardial fluid that can be serous, hemorrhagic, or 
purulent, depending on the etiology. Snyder et al observed 
that acute pericarditis is reported in 5% of patients 
presented to the emergency room for chest pain [1]. 
Cardiac tamponade is a critical condition, that occurs after 
rapid or excessive accumulation of pericardial fluid, 
associated with hemodynamic instability.  
The prevalence of pericarditis can be difficult to 
estimate because in some cases the accumulation of 
pericardial fluid can be clinically insignificant. The 
incidence of pericardial diseases is estimated to be 2 cases 
per 10 000 persons [2]. 
Pericardial effusion is classified by its onset as acute, 
subacute, or chronic and by its distribution in 
circumferential or loculated. Pericardial effusion is 
classified also based on hemodynamic impact (with or 
without cardiac tamponade) or by its composition (exudate, 
transudate, hemopericardium, pyo-pericardium). 
Depending on the effusion volume, pericardial effusion can 
be mild, moderate, or large [1]. 
Discussions 
Etiology of pericardial effusion 
The etiology of pericardial effusion is varied (Table 1). 
The 2015 European Society of Cardiology Guideline for 
the management of pericardial effusion classified the 
etiology into infectious and non-infectious [3]. Among 
infectious causes, the most common agents are viruses, 
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such as Coxsackie A and B, echovirus, adenovirus, 
influenza, and human herpes virus. Bacterial infections that 
can lead to pericardial effusion are represented by Coxiella 
burnetii, meningococcus, pneumococcus, staphylococcus 
and streptococcus [4]. 
A review by Mayosi et al in 2005 reported that 
tuberculosis is the most common cause of pericarditis in 
developing countries [5]. Another review reported that the 
incidence of tuberculous pericarditis is increasing in 
Africa, as a result of the HIV epidemic [6]. 
 
   Table 1. The etiology of pericardial effusion [3,7]. 
1.1. Infectious causes of pericardial effusion 
Viral 
Enteroviruses (Coxsackie viruses, Echoviruses), Herpes viruses, Epstein-Barr virus, 
cytomegalovirus, adenoviruses, parvovirus B19 
Bacterial 
Mycobacterium tuberculosis, Coxiella, Borrelia, pneumococcus, meningococcus, gonococcus, 
streptococcus, Chlamydia, Mycoplasma, Legionella 
Fungal Histoplasma, Aspergillus, Candida 
Parasitic Echinococcus, Toxoplasma 
1.2. Non-infectious causes of pericardial effusion 
Autoimmune 
Systemic autoimmune and auto-inflammatory diseases (systemic lupus erythematosus, Sjogren 
syndrome, rheumatoid arthritis, systemic vasculitides, sarcoidosis, inflammatory bowel diseases 
Neoplastic 
primary tumors (pericardial mesothelioma), secondary metastatic tumors (lung and breast 
cancer, lymphoma) 
Metabolic uremia, myxedema 
Traumatic and 
iatrogenic 
direct or indirect thoracic injury, postmyocardial infarction syndrome, post-pericardiotomy 
syndrome, after iatrogenic cardiac procedures 
Other 
amyloidosis, aortic dissection, pulmonary arterial hypertension, chronic heart failure, partial or 
complete congenital absence of the pericardium 
Drug-related 
procainamide, hydralazine, methyldopa, doxorubicin, 5-fluorouracil, amiodarone, mesalazine, 
bromocriptine 
 Pericardial effusion can be secondary to noninfectious 
diseases, such as autoimmune diseases (systemic lupus 
erythematosus, rheumatoid arthritis, Sjogren syndrome, 
sarcoidosis), primary tumors (pericardial mesothelioma) or 
secondary tumors (most common lung cancer and breast 
cancer, lymphomas and melanoma), acute myocardial 
infarction (Dressler syndrome), chronic renal failure [8], 
hypothyroidism (myxedema), mediastinal radiation, direct 
injury (penetrating thoracic injury), drugs (especially 
procainamide, hydralazine), and after an invasive cardiac 
procedure (post-pericardiotomy syndrome), or it may have 
hemodynamic causes (heart failure, pulmonary 
hypertension) [3]. In a study that enrolled 114 patients with 
neoplasia, pericardial diseases were diagnosed in 18% of 
cases throughout the monitoring period [9]. 
In many cases, the etiology of pericarditis is difficult to 
establish. Multiple studies on this issue have revealed that 
the cause of pericarditis is idiopathic in 90% of cases [4]. 
Cardiac tamponade can be caused by chest trauma 
complicated with pericardial hemorrhage 
(hemopericardium), ventricular wall rupture after acute 
myocardial infarction, or after invasive cardiac procedures 
[3].  
Pathophysiology of pericardial effusion 
The pericardium has the role to provide mechanical 
protection to the heart, to act as a barrier against infections, 
and to ensure dynamic interactions of the heart chambers. 
The normal pericardium contains 10-50 mL of pericardial 
fluid, which is an ultrafiltrate of plasma. The interactions 
of the pericardium with pleural lymphatics and the 
lymphatic drainage of the pericardial fluid to the 
mediastinal and tracheobronchial lymph nodes explain the 
pathological involvement of the pericardium in pulmonary 
diseases [9].  
Depending on the mechanism of appearance, the 
pericardial effusion can be classified into exudate and 
transudate. Pericardial fluid is an exudate when it is the 
result of an inflammatory pericardial process, which 
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determines an increased production of pericardial fluid. 
The transudate appears when the reabsorption of the 
pericardial fluid decreases due to the increased systemic 
venous pressure; thus, the fluid accumulates in the 
pericardium, as in heart failure or pulmonary hypertension 
[4]. 
The normal pericardium has a J-shaped pressure-
volume curve. A slow accumulation of 1-2 L of pericardial 
fluid, over several weeks or months, will lead to a modest 
increase in pericardial pressure, without cardiac tamponade 
until advanced stages [10]. Usually, pericardial effusions 
caused by infections, autoimmune diseases, or 
malignancies are associated with a slow accumulation of 
the fluid. In these cases, the compliance of the pericardium 
increases, and the pericardial sac dilates without 
compression of the heart [4]. 
A sudden increase in the pericardial fluid is associated 
with increased intrapericardial pressure. Intrapericardial 
pressure increases rapidly to 20-30 mmHg or more at a 
sudden increase of 100-200 mL of pericardial fluid (in 
cases of hemopericardium) and this can lead to cardiac 
tamponade [11]. Cardiac tamponade results from the rapid 
accumulation of the pericardial fluid. In the development 
of cardiac tamponade, some factors influence the 
hemodynamic consequences. These factors are represented 
by the rapidity of fluid accumulation, subjacent cardiac 
disease and the pericardial pressure-volume relationship. 
The ongoing accumulation of pericardial fluid increases 
the intrapericardial pressure. The compensatory 
mechanisms are the increased central systemic pressure 
and pulmonary venous pressure, for equalizing the 
pericardial pressure and preventing the collapse of the 
heart. Stroke volume is reduced, but in the first stages, the 
cardiac output is maintained. Also, the increased 
ventricular pressure leads to pulmonary hypertension to 
maintain pulmonary circulation. In these cases, pulmonary 
arterial pressure increases to 40 mmHg [12,13]. 
As the pericardial fluid continues to accumulate, the 
pericardium becomes inextensible. A discordance in filling 
and ejection between the left and the right ventricle will 
appear. This is called ventricular interdependence, 
meaning that any changes that appear in the volume of one 
side of the heart determine the opposite changes in the 
volume of the other side. The clinical manifestation that 
appears in this context is represented by pulsus paradoxus. 
The dilatation of the right ventricle leads to the bowing of 
the interventricular septum into the left ventricle, with a 
reduced left ventricle preload. When the pericardial 
pressure is above 25 mmHg, the cardiac output is 
decreased and the blood pressure is reduced, resulting in 
cardiogenic shock and circulatory collapse [14]. The 
pericardial drainage and removal of 100 mL of fluid may 
reduce the pericardial pressure, which is lifesaving in 
cardiac tamponade [15]. 
Clinical presentation and paraclinical tests 
Clinical presentation of pericardial effusion is variable, 
depending on the volume of fluid and rate of accumulation. 
Clinical manifestations are dramatic if the pericardial fluid 
accumulates rapidly. Classical symptoms in pericardial 
effusion include pleuritic chest pain, relieved when the 
patient leans forward, associated with dyspnea at exertion 
that can progress to orthopnea. Other symptoms may 
appear due to local compression, such as nausea and 
dysphagia. Depending on the etiology of pericardial fluid, 
nonspecific symptoms may appear, such as cough, 
weakness, palpitations, or fatigue [3]. 
Cardiac auscultation reveals diminished heart sounds. 
Pulmonary auscultation identifies sometimes a left 
parasternal pericardial friction rub. This is a sound 
corresponding to friction between the pericardium layers. 
In the literature, the friction rub is reported in 35-85% of 
the cases of pericarditis [16]. Physical examination in 
cardiac tamponade reveals jugular venous distension, 
tachypnea, tachycardia, pulsus paradoxus, hypotension, 
and cold extremities. Pulsus paradoxus means a decrease 
in systolic blood pressure by more than 10 mmHg with 
inspiration [6]. Pulsus paradoxus appears in cardiac 
tamponade due to ventricular interdependence, when the 
volume of the cardiac chambers is fixed. The classical 
finding at the physical examination in patients with cardiac 
tamponade is Beck’s triad, which includes arterial 
hypotension, jugular venous distension, and muffled heart 
sounds [17]. Data from the literature reveal that signs of 
Beck’s triad are identified especially in cases of cardiac 
tamponade due to hemopericardium, as a result of thoracic 
injury or acute rupture of the ventricular wall [4].  
Laboratory tests may show leukocytosis and high levels 
of inflammatory markers in pericardial effusion caused by 
infectious and inflammatory diseases. Also, in these cases, 
liver and renal function must be evaluated, together with 
thyroid stimulating hormone, and different markers in case 
of suspected viral infection. In cases of high suspicion of 
tuberculosis, tests such as PPD or quantiferon TB will be 
performed [10]. 
The electrocardiogram (ECG) performed in patients 
with pericarditis shows changes that evolve through stages 
[11]. In stage I, the ECG presents a diffuse elevation of the 
ST-segment. In stage II, the ST segment normalizes. Stage 
III and stage IV are characterized by T wave inversions, 
followed by T wave normalization. ECG changes appear in 
more than half of the patients [18]. In cardiac tamponade, 
the ECG reveals sinus tachycardia and low-voltage 
complexes. Electrical alternation on ECG is characteristic 
in cases of large pericardial effusion.  
The European Society of Cardiology guideline for 
pericardial diseases requires two out of the following four 
criteria for the diagnosis of acute pericarditis: pericardial 
chest pain, pericardial rub, ST-segment elevation on ECG 
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and pericardial effusion [3]. In cases of tuberculous 
pericardial effusion, the diagnosis is made when there are 
a lymphocytic pericardial exudate and elevated ADA 
levels [6]. 
Transthoracic echocardiography is the gold standard 
method for the diagnosis of pericardial effusions. M-mode 
and two-dimensional Doppler ecocardiography should be 
performed to evaluate the pericardial fluid, its distribution, 
size, and hemodynamic effects [16]. On two-dimensional 
echocardiography, pericardial effusion appears as an echo-
free space. In this case, the clinician should assess the 
location of the fluid and the hemodynamic impact. Small 
pericardial effusions are localized over the postero-basal 
left ventricle. Then, as the pericardial fluid increases, it will 
be visible anterior or lateral. Any pericardial effusion from 
5 to 10 mm in diastole is considered small, 10 to 20 mm is 
moderate, and greater than 20 mm is considered large. 
Swinging heart is a sign of large effusion at 
echocardiography [10]. 
In cardiac tamponade, echocardiography will show the 
diastolic collapse of the right heart cavities, the most 
characteristic ultrasonographic sign [19]. Usually, the 
compression of the right atrium for more than one-third of 
the cardiac cycle is specific for cardiac tamponade [20]. 
The collapse of the left atrium appears in 25% of the cases 
of tamponade [21]. Also, Doppler echocardiography is 
used to estimate respiratory variations in the mitral and 
tricuspid flow –a decrease in the peak mitral inflow 
velocity with >30% and an inspiratory increase of the peak 
of tricuspid inflow velocity with >50% suggest an 
increased ventricular interdependence [22]. The inferior 
vena cava is dilated in these cases and shows a less than 
50% reduction of its diameter during inspiration, as a sign 
of an increased central venous pressure [23]. The 
echocardiographic changes of the inferior vena cava 
associated with pulsus paradoxus at the physical 
examination are present in 92% of cases of cardiac 
tamponade [24]. Also, echocardiography will show 
abnormal septal motion in the case of cardiac tamponade. 
The clinician should correlate the echocardiographic 
signs of cardiac tamponade, such as collapse of the right 
atrium and right ventricle, respiratory alteration of mitral 
and tricuspid flow, and changes of the inferior vena cava, 
with the clinical signs of tamponade – dyspnea, 
tachycardia, jugular venous distension, pulsus paradoxus, 
hypotension, and shock [25]. 
Other imaging tests, such as computed tomography 
(CT) scan or magnetic resonance imaging (MRI) can 
describe the characteristics of the pericardial effusion and 
cardiac tamponade. The cardiac CT scan may reveal 
pericardial fluid accumulation, but this method cannot be 
used to assess hemodynamic parameters. The cardiac MRI 
evaluates the pericardium morphology but requires more 
time and has higher costs [26].  
The biochemical analysis of the pericardial fluid is 
recommended to assess the etiology of the pericardial 
effusion [3]. These tests can determine whether the 
etiology of the pericardial fluid is infectious or neoplastic. 
The pericardial fluid required for these tests will be 
obtained by pericardial drainage, and cultures for aerobes 
and anaerobes will be performed, together with other tests, 
depending on the suspected etiology. Also, the biochemical 
analysis of the pericardial fluid can distinguish the exudate 
from transudate [27]. 
Differential diagnosis of pericardial effusion 
There are several diseases with similar symptoms that 
should be considered in the differential diagnosis of 
pericardial effusion, such as pulmonary embolism, 
congestive heart failure, acute coronary syndrome, and 
cardiogenic pulmonary edema. In these cases, the 
differential diagnosis is based on the chest pain 
characteristics, laboratory tests (cardiac enzymes, D-
dimers, NT-proBNP), and imaging investigations 
(echocardiography, CT scan). Other causes of chest pain 
that should be considered in these patients are represented 
by gastritis, esophagitis, or peptic ulcer disease [11]. Also, 
the differential diagnosis of cardiac tamponade includes 
other causes of cardiogenic shock, such as pulmonary 
embolism or type A aortic dissection with extension into 
the pericardium [2]. 
Treatment of pericardial effusion 
Medical treatment 
Medical treatment in patients diagnosed with 
pericardial effusion whose tests show elevated 
inflammatory markers and develop inflammatory signs and 
symptoms, such as fever, is represented by high dose of 
non-steroidal anti-inflammatory drugs (NSAIDs) or 
aspirin, associated with colchicine [3] (Table 2). Several 
studies showed good results when colchicine is associated 
with aspirin or NSAIDs in the treatment of pericarditis 
[28]. Idiopathic and viral pericarditis associated with 
pericardial effusion is often responsive to this combination 
of drugs [29,30]. The treatment will be targeted for the 
causative agent in cases where the specific etiology is 
known (viral or bacterial infections). Low or moderate 
doses of corticosteroids are not recommended as first-line 
treatment, because this class is associated with the risk of 
recurrent pericarditis. Corticosteroids are administered 
usually when there are specific indications or in cases of 
intolerance to aspirin or NSAIDs [28]. The therapeutic 
response is evaluated based on the relief of the symptoms, 
associated with an improvement of the biological 
parameters.            
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Table 2. Drug treatment options for pericardial effusion [3]. 
Drug Usual dose Duration Lowering doses 
Aspirin 750-1000 mg every 8h 1-2 weeks Decrease doses by 250-500 mg every 1-2 weeks 
Ibuprofen 600 mg every 8h 1-2 weeks Decrease doses by 200-400 mg every 1-2 weeks 
Colchicine 
0.5 mg b.i.d (>70 kg) or 
0.5 mg once (<70 kg) 
3 months Not mandatory 
Corticosteroid 
0.2-0.5 mg/kg/day of 
Prednisone 
 
− at 50 mg/day: tapering with 10 mg/day every 
1-2 weeks 
− 25-50 mg: 5-10 mg/day every 1-2 weeks 
− 15-25mg: 2.5 mg/day every 2-4 weeks 
When a complete response is obtained, lowering doses 
should be considered, initially with a single class of drugs 
at a time. Each tapering is done if the patient is 
asymptomatic and the values of inflammatory markers are 
normal [3].  
Pericardial effusion developed after acute myocardial 
infarction complicated with rupture of the ventricle wall 
may result in hemopericardium. Studies show that up to 
two-thirds of these patients may present cardiac tamponade 
in the context of ventricular free wall rupture. In these 
cases, urgent treatment is life-saving [31]. 
Purulent pericardial effusion is associated with high 
mortality, so these patients should be treated aggressively. 
In the context of a tuberculous etiology of pericardial 
effusion, the treatment includes anti-tuberculosis drugs 
administered for at least 6 months. In these cases, the 
clinician should consider pericardiectomy if there is a 
failure of clinical improvement with medical therapy [32]. 
If the medical treatment is not effective in case of 
symptomatic pericardial effusion with no inflammatory 
signs, the clinician may consider pericardial drainage. 
Pericardial drainage 
Pericardial drainage can be performed by 
pericardiocentesis or by an open surgical method. 
Percutaneous needle pericardiocentesis is a procedure used 
for diagnosis or therapeutic purposes. In cases of 
symptomatic large pericardial effusion or cardiac 
tamponade, pericardiocentesis is the most useful 
therapeutic procedure. This is a life-saving method, 
indicated when echocardiography shows diastolic 
pericardial effusion >20 mm associated with hemodynamic 
impact [18]. 
Also, pericardiocentesis is performed in patients with 
chronic idiopathic pericardial effusion who remain 
asymptomatic, but who can develop unexpected 
tamponade. In a study performed by Sagrista et al, who 
followed patients diagnosed with chronic idiopathic 
pericardial effusion, cardiac tamponade appeared in 29% 
of cases during the course of the disease [7]. Numerous 
studies on this issue have confirmed that complications are 
reduced with 20% when percutaneous pericardiocentesis is 
guided by transthoracic echocardiography [33]. The 
feasibility of pericardiocentesis is 90% in cases when the 
pericardial fluid is localized anterior to the ventricle and 
<60% in cases of posterior localization [34]. 
Pericardiocentesis involves the removal of pericardial fluid 
by percutaneous catheterization of the pericardium, being 
an urgent procedure in cases of acute tamponade [18]. 
There are three approaches for pericardiocentesis – left 
parasternal, sub-xyphoid and left apical. Usually, the sub-
xyphoid approach is used to avoid injury of the major 
arteries [33].  
Halpern et al suggested a pericardial effusion scoring 
index, which consists of 3 components: the etiology of 
pericardial effusion, the size of the effusion, and 
echocardiographic signs. According to this index, 
pericardiocentesis could be performed when the score is 4 
or higher [35]. Hyun et al conducted a study in 2007 on 116 
patients diagnosed with symptomatic pericardial effusions, 
who were treated by pericardiocentesis guided by 
echocardiography. Common causes of pericardial effusion 
in these patients were lung cancer in 27% of cases, 
tuberculosis in 13.8%, and uremia in 6.9% of patients. 
Pericardiocentesis performed in these cases had a rate of 
success of 99.1% [18]. 
Malignant pericardial effusion can be a complication of 
lung or breast cancer or lymphomas. In these cases, 
pericardial drainage can be performed by 
pericardiocentesis or by surgical drainage, depending on 
the patient’s prognosis and risks. Many patients with a 
malignant pericardial effusion have a poor prognosis; in 
this context, the purpose of the treatment is to improve the 
quality of life [20].  
Tsang et al confirmed that echocardiography can 
rapidly confirm the presence of pericardial effusion after 
cardiothoracic surgery. In these cases, pericardiocentesis 
performed under echocardiographic guidance is safe and 
efficient. Also, it was confirmed that the use of a 
pericardial catheter for drainage is associated with lower 
recurrence rates [36]. Lindenberger et al conducted a 
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retrospective study, which included 252 patients with 
pericardial effusion. This study confirmed that 
pericardiocentesis guided by echocardiography is a safe 
and efficient method for patients with malignant etiology 
of the pericardial effusion [37]. 
Retrospective studies and case reports indicate 
pericardiocentesis with prolonged drainage (<30 mL/24h) 
to prevent re-accumulation of the fluid [35]. In cases when 
pericardiocentesis fails or is not feasible, the clinician 
should consider performing a pericardial window [24]. 
This technique uses sub-xyphoid approach under 
echocardiographic guidance and involves the insertion of a 
catheter into the pericardial space. This technique is 
efficient in preventing recurrence in >80% of cases [38]. 
The most important complications of 
pericardiocentesis are represented by perforation of the 
myocardium, injury of the coronary arteries, 
pneumothorax, air embolism, or puncture of the peritoneal 
cavity [34]. These complications are reduced by using the 
echocardiographic guidance. In a large review on this 
issue, the incidence of complications in echocardiography-
guided pericardiocentesis was 1-1.6% [38]. 
Pericardiocentesis is contraindicated in aortic dissection. 
Surgical drainage is a method used when pericardial 
drainage performed by pericardiocentesis is not feasible or 
has failed. This method is used in cases of 
hemopericardium, purulent pericarditis, recurrent 
malignant effusion, or when the pericardial effusion is 
localized posterior [39]. Surgical drainage can be 
performed by different techniques: complete or partial 
pericardectomy, subxyphoid pericardiotomy, anterior 
transthoracic window, all methods having the same 
efficiency [40]. 
In cases of idiopathic moderate pericardial effusions, an 
echocardiographic follow-up will be necessary every 6 
months. Patients with severe pericardial effusion require an 
echocardiographic reassessment every 3-6 months after 
discharge [41]. 
Evolution and prognosis 
The prognosis for patients with pericardial effusion 
depends on etiology. Patients with a neoplastic pericardial 
effusion have a poor prognosis. The evolution is favorable 
in patients with viral or idiopathic pericardial effusion. 
Also, the size of the effusion is correlated with prognosis. 
A mild idiopathic effusion is associated with a good 
prognosis and does not need special monitoring, the 
patients being mostly asymptomatic. Large pericardial 
effusions are associated with a high risk of progression to 
cardiac tamponade. Moderate to large pericardial effusions 
may evolve to cardiac tamponade in up to one-third of 
cases [3]. 
Recurrent pericardial effusion can occur in 30% of cases 
when patients are not treated with colchicine [3]. Another 
complication is constrictive pericarditis, which occurs in 
<1% of cases [5]. The most feared complication in patients 
with pericardial effusion is represented by cardiac 
tamponade. This complication rarely occurs in cases of 
idiopathic pericardial effusion but is more common in 
neoplastic forms [4]. 
Highlights 
✓ The etiology of pericardial effusion is diverse, from 
infectious diseases, malignancies, autoimmune 
diseases, chronic renal failure, to drug-related or after 
an invasive cardiac intervention. 
✓ Classical symptoms in pericardial effusion include 
pleuritic chest pain, associated with dyspnea. 
✓ Transthoracic echocardiography is the gold standard 
investigation for the diagnosis of pericardial effusions. 
The echocardiographic signs of cardiac tamponade are 
represented by the collapse of the right atrium and 
right ventricle, respiratory alteration of mitral and 
tricuspid flow, and changes of the inferior vena cava. 
✓ Pericardiocentesis guided by echocardiography is a 
life-saving procedure in cases of large pericardial 
effusions and cardiac tamponade. 
Conclusions 
Pericardial effusion may have different etiologies, such 
as infectious diseases, malignancies, chronic renal failure, 
thyroid disease, or autoimmune diseases, after cardiac 
interventions, or it can be idiopathic. Transthoracic 
echocardiography is the most useful investigation for the 
diagnosis of pericardial effusion. Large pericardial 
effusions require pericardial drainage performed by 
percutaneous pericardiocentesis or by surgical procedure.  
Pericardiocentesis guided by echocardiography is a life-
saving procedure in cases of large pericardial effusions and 
cardiac tamponade.  
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